PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22859722-0	2012	Cytochrome p450 architecture and cysteine nucleophile placement impact raloxifene-mediated mechanism-based inactivation.	Raloxifene Hydrochloride	71-81	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	11-15	
22859722-4	2012	Every P450 tested except CYP2E1 was capable of raloxifene bioactivation, based on glutathione adduct formation.	Raloxifene Hydrochloride	47-57	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	6-10	
22859722-3	2012	Raloxifene, a drug known to undergo CYP3A-mediated reactive metabolite formation and time-dependent inhibition in vitro, was used to explore the potential for bioactivation and enzyme inactivation of additional P450 enzymes (CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A5).	Raloxifene Hydrochloride	0-10	cytochrome P450 family 2 subfamily B member 6	Homo sapiens	211-215